pbs tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says ADA 2025: Advances in Type

The FDA-approved trials for tirzepatide included diverse populations, though specific post-cholecystectomy subgroup data remains limited

GLP-1 Meal Replacement Market Exclusions The scope does not include prescription medicines, standard protein powders with no meal-replacement positioning, general sports drinks, or unfortified snack products sold without meaningful nutritional replacement logic

Very common and common effects GLP-1 medicines often affect the digestive system, especially during titration

State medical boards are reviewing telehealth prescribing practices to ensure evaluations meet appropriate standards of care